Abstract:Age-dependent neurodegenerative diseases progressively form aggregates containing both shared components (e.g., TDP-43, phosphorylated tau) and proteins specific to each disease. We investigated whether diverse neuropathies might have additional aggregation-prone proteins in common, discoverable by proteomics. Caenorhabditis elegans expressing unc-54p/Q40::YFP, a model of polyglutamine array diseases such as Huntington's, accrues aggregates in muscle 2-6days posthatch. These foci, isolated on antibody-coupled magnetic beads, were characterized by high-resolution mass spectrometry. Three Q40::YFP-associated proteins were inferred to promote aggregation and cytotoxicity, traits reduced or delayed by their RNA interference knockdown. These RNAi treatments also retarded aggregation/cytotoxicity in Alzheimer's disease models, nematodes with muscle or pan-neuronal A(1-42) expression and behavioral phenotypes. The most abundant aggregated proteins are glutamine/asparagine-rich, favoring hydrophobic interactions with other random-coil domains. A particularly potent modulator of aggregation, CRAM-1/HYPK, contributed <1% of protein aggregate peptides, yet its knockdown reduced Q40::YFP aggregates 7286% (P<10(-6)). In worms expressing A(1-42), knockdown of cram-1 reduced -amyloid 60% (P<0.002) and slowed age-dependent paralysis >30% (P<10(-6)). In wild-type worms, cram-1 knockdown reduced aggregation and extended lifespan, but impaired early reproduction. Protection against seeded aggregates requires proteasome function, implying that normal CRAM-1 levels promote aggregation by interfering with proteasomal degradation of misfolded proteins. Molecular dynamic modeling predicts spontaneous and stable interactions of CRAM-1 (or human orthologs) with ubiquitin, and we verified that CRAM-1 reduces degradation of a tagged-ubiquitin reporter. We propose that CRAM-1 exemplifies a class of primitive chaperones that are initially protective and highly beneficial for early reproduction, but ultimately impair aggregate clearance and limit longevity.

Protein G-quadruplex interactions and their effects on phase transitions and protein aggregation

Protein G-quadruplex interactions and their effects on phase transitions and protein aggregation

Unearthing a novel function of SRSF1 in binding and unfolding of RNA G-quadruplexes

Manipulating TDP43 Aggregation via RNA G-quadruplexes

Predicting nuclear G-quadruplex RNA-binding proteins with roles in transcription and phase separation

HNRNPH1 destabilizes the G-quadruplex structures formed by G-rich RNA sequences that regulate the alternative splicing of an oncogenic fusion transcript

Proteins in Aggregates Functionally Impact Multiple Neurodegenerative Disease Models by Forming Proteasome-Blocking Complexes

The Disordered Protein SERF Promotes Α-Synuclein Aggregation Through Liquid-Liquid Phase Separation

Cross-Effects in Folding and Phase Transitions of hnRNP A1 and C9Orf72 RNA G4 In Vitro

Progress on the Recognition, Complex Structure and Intracellular Detection of Nucleic Acid G-quadruplex

Molecular insights into the interaction between a disordered protein and a folded RNA

In Cellulo Protein-mRNA Interaction Assay to Determine the Action of G-Quadruplex-Binding Molecules

Visualizing liquid-liquid phase transitions

RNA-dependent proteome solubility maintenance in Escherichia coli lysates analysed by quantitative mass spectrometry: Proteomic characterization in terms of isoelectric point, structural disorder, functional hub, and chaperone network

Diverse Roles of ScSERF in Modifying the Fibril Growth of Amyloidogenic Proteins

The role of RNA G‐quadruplexes in human diseases and therapeutic strategies

Biological Function and Medicinal Research Significance of G-Quadruplex Interactive Proteins.

A Compendium of G-Flipon Biological Functions That Have Experimental Validation

To Unwind the Biological Knots: the DNA/RNA G‐quadruplex Resolvase RHAU (DHX36) in Development and Disease

A Quantitative Proteomic Approach for the Identification of DNA Guanine Quadruplex-Binding Proteins